vs

Side-by-side financial comparison of Finance of America Companies Inc. (FOA) and ImmunityBio, Inc. (IBRX). Click either name above to swap in a different company.

Finance of America Companies Inc. is the larger business by last-quarter revenue ($73.5M vs $38.3M, roughly 1.9× ImmunityBio, Inc.). Finance of America Companies Inc. runs the higher net margin — -14.1% vs -161.8%, a 147.7% gap on every dollar of revenue. On growth, ImmunityBio, Inc. posted the faster year-over-year revenue change (407.0% vs 248.7%).

Rocket Companies, Inc., is an American fintech and homeownership services company. Founded by Dan Gilbert and based in Downtown Detroit, Michigan, the company is one of the largest mortgage lenders in the United States through its flagship subsidiary Rocket Mortgage. Its subsidiaries include Redfin, Forsalebyowner.com, and Rocket Money.

ImmunityBio, Inc. is a clinical-stage biotechnology company focused on developing next-generation immunotherapies and vaccine candidates targeting multiple cancer types and infectious diseases. It operates mainly in the U.S. market, with core R&D segments including cell therapy, antibody therapeutics, and targeted vaccine platforms designed to enhance patient treatment outcomes.

FOA vs IBRX — Head-to-Head

Bigger by revenue
FOA
FOA
1.9× larger
FOA
$73.5M
$38.3M
IBRX
Growing faster (revenue YoY)
IBRX
IBRX
+158.2% gap
IBRX
407.0%
248.7%
FOA
Higher net margin
FOA
FOA
147.7% more per $
FOA
-14.1%
-161.8%
IBRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FOA
FOA
IBRX
IBRX
Revenue
$73.5M
$38.3M
Net Profit
$-10.4M
$-61.9M
Gross Margin
99.0%
Operating Margin
-29.9%
-169.0%
Net Margin
-14.1%
-161.8%
Revenue YoY
248.7%
407.0%
Net Profit YoY
82.4%
-4.7%
EPS (diluted)
$0.45
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FOA
FOA
IBRX
IBRX
Q4 25
$73.5M
$38.3M
Q3 25
$80.8M
$32.1M
Q2 25
$177.4M
$26.4M
Q1 25
$165.7M
$16.5M
Q4 24
$-49.4M
$7.6M
Q3 24
$290.1M
$6.1M
Q2 24
$79.0M
Q1 24
$74.7M
Net Profit
FOA
FOA
IBRX
IBRX
Q4 25
$-10.4M
$-61.9M
Q3 25
$-9.5M
$-67.3M
Q2 25
$34.9M
$-92.6M
Q1 25
$30.2M
$-129.6M
Q4 24
$-59.1M
$-59.2M
Q3 24
$84.2M
$-85.7M
Q2 24
$-2.1M
Q1 24
$-7.5M
Gross Margin
FOA
FOA
IBRX
IBRX
Q4 25
99.0%
Q3 25
99.4%
Q2 25
99.5%
Q1 25
99.6%
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
FOA
FOA
IBRX
IBRX
Q4 25
-29.9%
-169.0%
Q3 25
-35.3%
-173.5%
Q2 25
46.2%
-269.8%
Q1 25
49.3%
-390.1%
Q4 24
295.0%
-919.0%
Q3 24
71.8%
-1314.3%
Q2 24
-4.8%
Q1 24
-21.1%
Net Margin
FOA
FOA
IBRX
IBRX
Q4 25
-14.1%
-161.8%
Q3 25
-11.8%
-209.8%
Q2 25
19.7%
-350.3%
Q1 25
18.2%
-784.9%
Q4 24
119.5%
-783.4%
Q3 24
29.0%
-1404.0%
Q2 24
-2.6%
Q1 24
-10.1%
EPS (diluted)
FOA
FOA
IBRX
IBRX
Q4 25
$0.45
$-0.06
Q3 25
$-1.27
$-0.07
Q2 25
$2.13
$-0.10
Q1 25
$2.43
$-0.15
Q4 24
$-5.24
$-0.08
Q3 24
$7.50
$-0.14
Q2 24
$-0.30
Q1 24
$-0.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FOA
FOA
IBRX
IBRX
Cash + ST InvestmentsLiquidity on hand
$89.5M
$242.8M
Total DebtLower is stronger
$357.5M
Stockholders' EquityBook value
$395.6M
$-500.5M
Total Assets
$30.7B
$501.9M
Debt / EquityLower = less leverage
0.90×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FOA
FOA
IBRX
IBRX
Q4 25
$89.5M
$242.8M
Q3 25
$109.8M
$257.8M
Q2 25
$46.5M
$153.7M
Q1 25
$52.0M
$61.6M
Q4 24
$47.4M
$149.8M
Q3 24
$44.3M
$130.4M
Q2 24
$46.5M
Q1 24
$48.2M
Total Debt
FOA
FOA
IBRX
IBRX
Q4 25
$357.5M
Q3 25
$390.0M
Q2 25
Q1 25
Q4 24
$374.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FOA
FOA
IBRX
IBRX
Q4 25
$395.6M
$-500.5M
Q3 25
$365.8M
$-524.3M
Q2 25
$473.4M
$-570.7M
Q1 25
$394.9M
$-591.4M
Q4 24
$315.7M
$-489.1M
Q3 24
$456.5M
$-745.1M
Q2 24
$251.3M
Q1 24
$255.7M
Total Assets
FOA
FOA
IBRX
IBRX
Q4 25
$30.7B
$501.9M
Q3 25
$30.7B
$519.0M
Q2 25
$30.1B
$402.1M
Q1 25
$29.7B
$303.8M
Q4 24
$29.2B
$382.9M
Q3 24
$29.0B
$364.6M
Q2 24
$28.0B
Q1 24
$27.7B
Debt / Equity
FOA
FOA
IBRX
IBRX
Q4 25
0.90×
Q3 25
1.07×
Q2 25
Q1 25
Q4 24
1.19×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FOA
FOA
IBRX
IBRX
Operating Cash FlowLast quarter
$-429.7M
$-70.4M
Free Cash FlowOCF − Capex
$-71.3M
FCF MarginFCF / Revenue
-186.2%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-308.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FOA
FOA
IBRX
IBRX
Q4 25
$-429.7M
$-70.4M
Q3 25
$-149.7M
$-68.9M
Q2 25
$-96.5M
$-79.7M
Q1 25
$-92.1M
$-85.9M
Q4 24
$-423.8M
$-85.1M
Q3 24
$-81.4M
$-98.8M
Q2 24
$-104.0M
Q1 24
$-132.2M
Free Cash Flow
FOA
FOA
IBRX
IBRX
Q4 25
$-71.3M
Q3 25
$-69.6M
Q2 25
$-80.8M
Q1 25
$-87.0M
Q4 24
$-87.3M
Q3 24
$-101.6M
Q2 24
Q1 24
$-132.7M
FCF Margin
FOA
FOA
IBRX
IBRX
Q4 25
-186.2%
Q3 25
-217.2%
Q2 25
-305.9%
Q1 25
-526.9%
Q4 24
-1155.4%
Q3 24
-1663.2%
Q2 24
Q1 24
-177.7%
Capex Intensity
FOA
FOA
IBRX
IBRX
Q4 25
2.4%
Q3 25
2.3%
Q2 25
4.1%
Q1 25
6.8%
Q4 24
28.0%
Q3 24
45.7%
Q2 24
Q1 24
0.6%
Cash Conversion
FOA
FOA
IBRX
IBRX
Q4 25
Q3 25
Q2 25
-2.76×
Q1 25
-3.05×
Q4 24
Q3 24
-0.97×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FOA
FOA

Segment Continuing Operations$70.8M96%
Other$2.7M4%

IBRX
IBRX

Segment breakdown not available.

Related Comparisons